Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation

Blood Adv. 2022 Feb 8;6(3):746-749. doi: 10.1182/bloodadvances.2021005208.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Abatacept
  • Graft vs Host Disease* / etiology
  • Graft vs Host Disease* / prevention & control
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Transplantation Conditioning
  • Unrelated Donors

Substances

  • Abatacept